Thermo Fisher Expands Bioprocessing Capabilities with $4 Billion Acquisition of Solventum’s Purification and Filtration Division

In a strategic move to enhance its bioprocessing capabilities, Thermo Fisher Scientific has announced the acquisition of the Purification and Filtration business segment from Solventum, a spinoff of 3M. The deal, valued at $4 billion, positions Thermo Fisher to significantly expand its offerings in the biopharmaceutical manufacturing sector.

The acquired business is renowned for its high-quality filters and membranes that are critical in various global applications within the biopharmaceutical industry. This acquisition not only broadens Thermo Fisher’s portfolio but also strengthens its position as a leader in serving science and technology markets.

Dare: February 25, 2025.

Newsflash | Powered by GeneOnline AI

Related posts:

What the PlayStation Network Outage Can Teach the Biotech Industry GLP-1 Weight Loss Drugs Might Cause Blindness Massive Data Analysis Advances Understanding of How Immunotherapy Works Cancerous Breast Tissue Glows in New AI-Enhanced MRI Images

Author

Mark Chiang

Ph.D in Biomedical Informatics Head of AI at GeneOnline